IBB ETF holdings (NASDAQ) - Page 8 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

CRVS Corvus Pharmaceuticals, Inc. 6.66 M 445.67 K 0.07%

KURA Kura Oncology, Inc. 6.65 M 606.11 K 0.07%

SEPN Septerna, Inc. 6.45 M 192.65 K 0.07%

PGEN Precigen, Inc. 6.37 M 1.12 M 0.07%

OLMA Olema Pharmaceuticals, Inc. 6.23 M 498.32 K 0.07%

JANX Janux Therapeutics, Inc. 6.20 M 403.67 K 0.07%

REPL Replimune Group, Inc. 5.95 M 537.81 K 0.07%

ZVRA Zevra Therapeutics, Inc. 5.90 M 411.69 K 0.06%

PSNL Personalis, Inc. 5.86 M 437.15 K 0.06%

ANRO Alto Neuroscience, Inc. 5.85 M 221.51 K 0.06%

CGEM Cullinan Therapeutics, Inc. 5.81 M 318.93 K 0.06%

TBPH Theravance Biopharma, Inc. 5.79 M 340.42 K 0.06%

ANNX Annexon, Inc. 5.76 M 1.01 M 0.06%

ZBIO Zenas Biopharma, Inc. 5.70 M 224.45 K 0.06%

GERN Geron Corp. 5.67 M 4.43 M 0.06%

SLDB Solid Biosciences, Inc. 5.51 M 551.59 K 0.06%

BIOA BioAge Labs, Inc. 5.47 M 223.34 K 0.06%

ABUS Arbutus Biopharma Corp. 5.32 M 1.11 M 0.06%

CSTL Castle Biosciences, Inc. 4.97 M 208.27 K 0.05%

RIGL Rigel Pharmaceuticals, Inc. 4.94 M 126.16 K 0.05%

1
...
6
7
8
9
10
11
12
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026